Healthcare -
Biotechnology - NASDAQ - US
$ 8.64
3.97 %
$ 74 M
Market Cap
-0.35
P/E
SRZN - NET INCOME
Net Income SRZN - Surrozen, Inc.
-63.6 M
LAST VALUE
-32.87%
2 YEAR CAGR
-21.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR